November 24, 2014
UC San Diego Health System in partnership with the U.S. Hereditary Angioedema Association (HAEA), a non-profit patient advocacy organization, has opened the nation’s first dedicated center for diagnosing and treating diverse forms of swelling, known collectively as angioedema.
April 22, 2019
University of California San Diego School of Medicine researchers found that treating patients with personalized precision medicine that combined therapies to target multiple alterations improved outcomes in patients with therapy resistant cancers.
October 4, 2016
…latest treatments with a personalized medicine approach. This expertise led to the selection of Moores Cancer Center as one of 12 clinical trial sites for the Pancreatic Cancer Action Network’s newly created Precision Promise, the first large-scale precision medicine trial network designed to transform outcomes for patients with pancreatic cancer.
November 7, 2018
After eight years of study, a team of researchers from the University of California San Diego and Johns Hopkins University published new findings about how to read the body’s histone code in the Nov. 7 issue of Science Advances. The findings answer a key question in the dynamic research area…
November 2, 2015
Researchers at the University of California, San Diego have developed a model that could be used to predict a drug’s side effects on different patients. The proof of concept study is aimed at determining how different individuals will respond to a drug treatment and could help assess whether a drug…
December 4, 2014
…PrEP pill contains two medicines (tenofovir and emtricitabine) that are used in combination with other medicines to treat HIV. When someone is exposed to HIV through sex or injection drug use, these medicines can work to keep the virus from establishing a permanent infection. Kadakia explained how multiple studies followed…
June 6, 2016
…researchers at University of California San Diego School of Medicine report that therapeutic approaches using precision medicine, which emphasizes the use of individual genetics to refine cancer treatment, showed improved response and longer periods of disease remission, even in phase I trials.
October 17, 2017
…clinical trial over the next year designed to develop personalized cancer vaccines—a breakthrough treatment that could help patients like their daughter fight the disease using their own immune system.
June 8, 2021
Researchers at University of California San Diego School of Medicine used a combination of modalities, such as measuring brain function, cognition and lifestyle factors, to generate individualized predictions of depression.
February 5, 2015
…San Diego Department of Medicine Chair; and Dr. David Brenner, UC San Diego Health Sciences Vice Chancellor, UC San Diego School of Medicine Dean. It is rare for an “orphan” disease (typically a condition that affects fewer than 200,000 people nationwide) to have a specific center dedicated to providing treatment…
